KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Invested Capital (2016 - 2025)

Historic Invested Capital for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $2.5 billion.

  • Exact Sciences' Invested Capital fell 2208.66% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 2208.66%. This contributed to the annual value of $2.4 billion for FY2024, which is 2481.94% down from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Invested Capital is $2.5 billion, which was down 2208.66% from $2.5 billion recorded in Q2 2025.
  • Exact Sciences' 5-year Invested Capital high stood at $3.6 billion for Q1 2021, and its period low was $2.4 billion during Q1 2025.
  • In the last 5 years, Exact Sciences' Invested Capital had a median value of $3.2 billion in 2024 and averaged $3.1 billion.
  • In the last 5 years, Exact Sciences' Invested Capital soared by 5153.46% in 2021 and then plummeted by 2481.94% in 2024.
  • Over the past 5 years, Exact Sciences' Invested Capital (Quarter) stood at $3.4 billion in 2021, then fell by 10.17% to $3.0 billion in 2022, then increased by 5.0% to $3.2 billion in 2023, then decreased by 24.82% to $2.4 billion in 2024, then rose by 4.13% to $2.5 billion in 2025.
  • Its Invested Capital was $2.5 billion in Q3 2025, compared to $2.5 billion in Q2 2025 and $2.4 billion in Q1 2025.